baber/WOPTO huggingface dataset:
Patent AT-E161690-T1 (AT)
Inventor: SLANGEN HUBERTUS JOZEF MARIA
IPC: A23L27/30
Filed: 1993-06-08
Granted: 1998-01-15
Abstract: The invention relates to a process for the treatment of dried aspartame characterised in that, in a first separation step, particles smaller than 50  mu m are removed, with the aid of a stream of air, from aspartame having a particle size distribution with which more than 5 wt.% of the aspartame has a particle size of less than 20 mu m and more than 10 wt.% of the aspartame has a particle size of more than 400  mu m, and that in a second separation step the product resulting from the first step is subjected to a screening step using a screen that separates at a value between 150 and 250  mu m, after which the fraction of the smaller particles thus obtained is recovered as a first product and the fraction of the larger particles is recovered as a second product or is optionally subjected to a further separation step using a screen that separates at a value between 400 and 1000  mu m, the fraction of smaller particles thus obtained being recovered as the second product. Aspartame having a particle size distribution with which 97% of the particles is larger than 20  mu m and 97% of the particles is smaller than 250  mu m appears to present exceptionally good properties as regards processability and dissolution rate.
Patent AT-E122278-T1 (AT)
Inventor: MONTECCHI SANTE
IPC: B01F5/24
Filed: 1993-12-30
Granted: 1995-05-15
Abstract: A method for the manufacture of dry-moulded ceramic tiles having effects of veining distributed in the ceramic body, comprises forming a mass of granules or powders with stream tubes flowing distinctly at least in the upper part of said mass, extracting by gravity from the bottom of the mass a layer of powder by means of separate, selected feed-apertures; the plant comprising a hopper (11) containing the powders fed by an alternative distributor (28) having at least two feeding ducts: a grid (10) being slidably mounted below the hopper for feeding the die-matrix (12, 13) by means of a plurality of baffles defining the feed-apertures for the powder. <IMAGE>
Patent AT-E163496-T1 (AT)
Inventor: CHARBONNIER PHILIPPE
IPC: H04N1/32
Filed: 1992-11-26
Granted: 1998-03-15
Abstract: PCT No. PCT/FR92/01103 Sec. 371 Date Oct. 13, 1994 Sec. 102(e) Date Oct. 13, 1994 PCT Filed Nov. 26, 1992 PCT Pub. No. WO93/11628 PCT Pub. Date Jun. 10, 1993.A switchable data rate ISDN terminal for group G4 facsimile operation is disclosed. A decoder in the terminal automatically responds to a hexadecimal 7F formed by an extra bit added to the HDLC communications-starting flag when a 64 kb/s system transmits a 56 kb/s communication. The decoder responds by causing a speed controller in the terminal to reduce the effective data transfer rate.
Patent AT-E137257-T1 (AT)
Inventor: TRATZ HERBERT
IPC: C10B1/10
Filed: 1993-02-11
Granted: 1996-05-15
Abstract: To heat a drum (4) designed to generate low-temperature distillation gases (s), a heating gas (g) which passes round a heating-gas circuit (70, 72) is used. In order to enable the distillation plant (1) to be operated particularly efficiently, and also autonomously, the invention calls for the heating gas (g) to be produced by burning a part (t1?) of the distillation gases (s). In a distillation/combustion plant, in particular a combustion plant (2) retrofitted with a distillation plant (1), the remainder (t2?) of the distillation gases (s) produced is fed to the combustion chamber (34) of the combustion plant (2).
Patent AT-E156834-T1 (AT)
Inventor: WESTERMANN JUERGEN
IPC: C07J75/00
Filed: 1993-06-22
Granted: 1997-08-15
Abstract: PCT No. PCT/EP93/01606 Sec. 371 Date Apr. 18, 1995 Sec. 102(e) Date Apr. 18, 1995 PCT Filed Jun. 22, 1993 PCT Pub. No. WO94/04553 PCT Pub. Date Mar. 3, 1994.A process for the production of 1-methyl-3-keto- DELTA 1,4 steroids of general formula I    <IMAGE>  (I)  in which St symbolizes the radical of asteroid molecule, where a 3-keto- DELTA 1,4 steroid of general formula II    <IMAGE>  (II)  in which St has the above-mentioned meaning, is reacted in an inert solvent in the presence of a nickel salt soluble therein with an organometallic compound of formula III, IV or V   CH3ZnX, (III)   <IMAGE>d Z2 are as defined in the specification.
Patent AT-E166339-T1 (AT)
Inventor: WILLMAN NILS-ERIK
IPC: C07D295/08
Filed: 1993-07-20
Granted: 1998-06-15
Abstract: PCT No. PCT/SE93/00635 Sec. 371 Date Jan. 18, 1995 Sec. 102(e) Date Jan. 18, 1995 PCT Filed Jul. 20, 1993 PCT Pub. No. WO94/02442 PCT Pub. Date Feb. 3, 1994.    <IMAGE>  (I)  Compounds of formula (I) and their physiologically acceptable salts thereof, their use as therapeutical substances, pharmaceutical compositions containing them, and methods for preparing the compounds.
Patent AT-E140806-T1 (AT)
Inventor: FLAEMIG HARTMUT
IPC: G05B9/03
Filed: 1993-09-07
Granted: 1996-08-15
Abstract: An arrangement has several analog input units (AE1, AE2) to which sensors (TE1, TE2, KD) arranged at measurement sites and at a comparison site are connectable. The analog input units derive measurement values from the signals of the measurement site sensors and from the signal of the comparison site sensor (KD). The units can be switched between a first and a second mode of operation, in the first mode of operation, one of the units detects the signal from the comparison site sensor and in the second mode of operation the other units receive said signal. The comparison values can thus be determined with less complexity. The invention is applicable in analog input units of store programmable controls.
Patent AT-E148679-T1 (AT)
Inventor: SORG HELMUT DIPL-ING
IPC: C03B5/23
Filed: 1994-06-06
Granted: 1997-02-15
Abstract: A continuously flowing glass stream (32) is conditioned and homogenised in a treatment section which extends from an inlet side (26) of a working tank or of a distributor channel to at least one removal point and in which at least one cooling zone (K) is situated, which is followed by at least one homogenising zone for the glass temperature. In the working tank or the distributor channel, the temperature is lowered from an inlet temperature T1 to an outlet temperature T2. In order to guarantee the conditioning and homogenising effect even at high flow rates, a flow cross-section of the glass mass with a depth/width ratio D/W of a maximum of 0.6 or 0.5 or 0.4 or 0.3 or 0.2 is set in the at least one cooling zone (K) of the working tank or of the distributor channel by means of at least one sill-shaped raised part (23a) rising from the floor (23), the maximum depth Tmax being 300 or 250 or 200mm, and, in the glass stream (32), in the total of all cooling zones, at least 50 or 60 or 70% of the temperature difference between T1 and T2 is removed. <IMAGE>
Patent AT-E158896-T1 (AT)
Inventor: BUETTNER ALEX
IPC: H01H9/02
Filed: 1994-07-17
Granted: 1997-10-15
Abstract: The invention relates to a three-pole fused element for fitting directly onto busbar systems, which fuse element is completely encapsulated by a housing (1). The terminals of the outlet lines (20) are located at a level in the region of the lower end (17) of the housing (1). A plurality of ventilation slots (18, 19) are arranged in the region of the two housing ends. In order to cover the terminal screws and a channel-like depression (13), into which a latching lever projects having a bend (14) for fixing the fuse element on the busbars, to provide protection against electric shocks, covering flaps (28, 29) which can pivot are provided in the vicinity of the housing ends. The fuse element makes it possible to connect the outlet lines easily and safely, while providing improved electric shock protection, heating the element in use being avoided. <IMAGE>
Patent AT-E151924-T1 (AT)
Inventor: KNIER GUENTHER G
IPC: H02G3/18
Filed: 1994-07-18
Granted: 1997-05-15
Abstract: An underfloor equipment box for floors which are to be cleaned wet. Such an underfloor equipment box is known having a component which is designed as a cord outlet, is provided centrally in a cover of a protective frame and is bonded tightly in the cover, such that it projects from a top of the cover in the operation position, a circumferential seal being provided between the cover and the protective frame. According to the invention, the cover (2) is arranged on the protective frame (1) such that it can pivot and has a locking device (13 to 19; 38 to 41; 42 to 50) which holds the cover (2) in the locked position, pressed against the circumferential seal (5). <IMAGE>
Patent AT-E162356-T1 (AT)
Inventor: MCWILLIAMS JOSEPH ANTHONY
IPC: F24C7/06
Filed: 1994-02-01
Granted: 1998-01-15
Abstract: A radiant electric heater is manufactured by a method which involves providing a base (2) of microporous thermal and electrical insulation material having a substantially continuous surface, and providing a heating element (4) in the form of an elongate electrically conductive strip (5). The strip (5) is urged edgewise into the continuous surface of the base (2) of microporous thermal and electrical insulation material so as to embed and support the strip (5) edgewise in the insulation material along substantially the entire length of the strip to a depth corresponding to at least part of the height of the strip. <IMAGE>
Patent AT-E164315-T1 (AT)
Inventor: MEYER GABRIEL
IPC: A61J1/05
Filed: 1993-12-15
Granted: 1998-04-15
Abstract: PCT No. PCT/CH93/00282 Sec. 371 Date Jul. 19, 1994 Sec. 102(e) Date Jul. 19, 1994 PCT Filed Dec. 15, 1993 PCT Pub. No. WO94/13344 PCT Pub. Date Jun. 23, 1994The invention concerns a device for the preparation of a medicinal solution from two components, one of which is in powder, lyophilisate or liquid form and the other a dilutant or a liquid solvent. These components respectively are charged in a rear container (11) and a front container (13), each of which has an opening closed off by a stopper-piston-dish, which is axially movable. Both these stopper-piston-dishes (19, 24) are connected by a conveyance shaft (15) adapted to ensure a rigid, tight and sterile coupling between the two stopper-piston-dishes (19, 24) when the device (10) is in a charging position, and to define a channel between both these containers (11, 13) when the device is in a position of use. The stopper-piston-dishes (19, 24) have a central zone provided with a slit (31, 33)m which is strongly compressed and closed in tight fashion when the device is in charging position, and which is open when one end of the conveyance shaft (15) is introduced therein, the device then being in the position of use. FIG.
Patent AT-E172903-T1 (AT)
Inventor: ANDERSSON ERLAND
IPC: B22D11/04
Filed: 1994-01-04
Granted: 1998-11-15
Abstract: PCT No. PCT/SE94/00005 Sec. 371 Date Jun. 19, 1995 Sec. 102(e) Date Jun. 19, 1995 PCT Filed Jan. 4, 1994 PCT Pub. No. WO94/16844 PCT Pub. Date Aug. 4, 1994A device for continuously manufacturing a cast strand by continuous casting of liquid metal melt wherein the flow of the liquid metal in the non-solidified portions of the strand is controlled by means of a static or periodic low-frequency magnetic field. A mould adapted to be supplied with the melt includes copper plates (2a,2b) which form a casting mould space with a rectangular cross section, water box beams (3) which are arranged outside the copper plates to support and cool them, and a member (4) holding the mould together. Magnetic field-generating devices, i.e., magnets, are provided close to the mould to generate a static or periodic low-frequency magnetic field which acts in the path of the inflowing melt and divides the primary flow as well as checks any secondary flows arising. Each magnet comprises a front core (5), a rear core and a coil (7). The front core is a fully integral part of the water box beam and the rear core comprises a rear movable part (6b) which is movable in a direction which substantially coincides with the direction of the field.
Patent AT-E169932-T1 (AT)
Inventor: PASTAN IRA H
IPC: C12N15/02
Filed: 1994-06-14
Granted: 1998-09-15
Abstract: The present invention relates to disulfide-stabilized recombinant polypeptide molecules which have the binding ability and specificity for another peptide, such as the variable region of an antibody molecule. Methods of producing these molecules and nucleic acid sequences encoding these molecules are also described. In particular, the invention discloses Fv antibody fragments stabilized by a disulfide bond connecting the VH and VL regions of the Fv fragment. The alpha and beta chains of T cell receptors may be similarly stabilized by means described in the invention.
Patent AT-E155863-T1 (AT)
Inventor: GREENWOOD CHRISTOPHER JOHN
IPC: F16H9/00
Filed: 1994-09-22
Granted: 1997-08-15
Abstract: PCT No. PCT/GB94/02055 Sec. 371 Date Mar. 29, 1996 Sec. 102(e) Date Mar. 29, 1996 PCT Filed Sep. 22, 1994 PCT Pub. No. WO95/09996 PCT Pub. Date Apr. 13, 1995A method of controlling a vehicle driveline including an engine, a continuously variable ratio transmission (CVT) and a final drive in which over a working range of engine speed, the engine is constrained to work to a performance map correlating each value of engine speed to a particular value of engine torque wherein a demand by a driver for a increase in vehicle speed initiates a quick increase in engine speed to a predetermined engage speed without any substantial rise in the final drive speed and then increasing both engine speed and drive speed by a predetermined function until a selected engine speed limit is reached which is commensurate with the driver's demand, and finally maintaining the selected engine speed limit despite further changes in the final drive speed whereby the ratio range of the CVT is extended by providing two regimes of operation with a synchronous ratio between those regimes and the predetermined function is graphically represented as a straight line slope which corresponds to the slope the synchronous ratio. The invention also relates to a driveline controlled by the method.
Patent AT-E200082-T1 (AT)
Inventor: SUGIMOTO HIROHIKO
IPC: A61K31/415
Filed: 1993-01-15
Granted: 2001-04-15
Abstract: A novel imidazole derivatives of formula I: <CHEM> wherein R<1> is hydrogen, alkyl, halogen, or optionally substituted aryl; R<2> is alkyl, optionally substituted aryl optionally substituted aralkyl, or optionally substituted hetero ring group; R<3> is hydrogen, alkyl, optionally substituted aryl, optionally substituted aralkyl, or optionally substituted hydroxyalkyl; R<4> is hydrogen, alkyl, halogen, acyl, optionally substituted hydroxyalkyl, optionally esterified or amidated carboxyl group, hydroxy group, aryl or arylthio; X is S, SO, SO2, CH2, or Se; n is an integer of 1 to 3, or a pharmaceutically acceptable salt thereof, said derivative having anti-HIV activity and being useful for the treatment of HIV infections.
Patent AT-E156013-T1 (AT)
Inventor: LE BRAS VERONIQUE
IPC: A61K8/72
Filed: 1995-09-07
Granted: 1997-08-15
Abstract: Anhydrous compsns. for topical application are in the form of a supple paste and contain a silicone elastomer (I) and an oil phase contg. at least one wax.
Patent AT-E157060-T1 (AT)
Inventor: KEMMERICH HERBERT
IPC: B65D43/06
Filed: 1995-02-13
Granted: 1997-09-15
Abstract: The invention relates to a container characterized in that the interior (14) of the lid (2) when closed lies below the upper edge (3) of the container (1). The inside (15) of the lid edge surrounding the lid interior (14) has a reinforcement bead (16) running round it with a multiplicity of inwards-facing parallelepipedal projections (17) which connect the lid interior (15) to the inside of the lid edge. The outer part (6) of the lid edge running round the outside of the plastic container wall (4) has an ouwards-facing inclined slide surface (10) merging in an approximately vertical zone (11) which is located at a large distance from the container wall (4) and terminates close to the edge (8) running round the container. The aim of the invention is to increase the ability of the containers and their lids to resist damage when they are stacked one on top of the other, thus considerably facilitating the stacking process and avoiding damage to the edge of the lid by adjacent containers during stacking or transport on pallets for instance.
Patent AT-E172496-T1 (AT)
Inventor: KLATZMANN DAVID
IPC: C12N15/09
Filed: 1995-02-22
Granted: 1998-11-15
Abstract: Host-vector system for expression of a transgene in a target cell or human/animal tissue comprises a eukaryotic cell line transfected with:(a) a recombinant psuedo-retroviral sequence in which all or part of the env gene has been deleted, either totally or partially, and replaced by the transgene as shown in figure 1a, and(b) a nucleic acid sequence which includes a sequence which codes for an envelope protein, is under the control of a promoter, is opt. associated with the transgene and is flanked on its 3' end by a polyadenylation site as shown in figure 1b; provided that(c) both (a) and (b) are capable of trans-complementation to permit the host cell to produce infectious env-deficient virus particles. Also claimed are:(1) a process for the expression of a transgene for gene therapy which comprises:(i) constructing a host-vector system as above;(ii) contacting the system with the cells in which the transgene is to be expressed, and(iii) opt. retransferring the env-contg. sequence into the target cells;(2) a process for the expression of a transgene for gene therapy which comprises the double transfection of target cells with:(i) env-deficient virus particles obtd. using the above host-vector system, and(ii) a nucleic acid sequence contg. a retroviral env gene; where(iii) trans co-expression of the 2 sequences in vivo results in infectious env-deficient recombinant virus particles;(3) a recombinant viral vector contg. a transgene useful in gene therapy, where:(i)a gene essential to the constitution of infectious virus particles is replaced by the transgene;(ii)the essential gene is present on the same or a different vector but is not under the control of viral promoters, and(iii) the prod. of the gene is trans-acting and permits reconstitution of defective virus particles;(4) a medication for use in gene therapy, contg. "vehicles" contg.:(i) a recombinant retroviral sequence in which the env gene is replaced by a trans gene, and(ii) a sequence contg. an env gene under the control of a promoter, where the env-contg. sequence is outside the zone of regulation of the expression of the retroviral sequences, and(5) a medication for use in gene therapy, contg. eukaryotic cells which have been subjected to double transfection and are "represented" by the above host-vector system.
Patent AT-E246708-T1 (AT)
Inventor: METZ WILLIAM A JR
IPC: A61K38/55
Filed: 1995-05-05
Granted: 2003-08-15
Abstract: This invention relates to compounds which are inhibitors of elastase, particularly human neutrophil elastase. The inhibitors are short, synthetic peptides in which the P2 moiety is substituted with various nitrogen-containing heterocyclic groups. As inhibitors of human neutrophil elastase, the compounds are useful in the treatment of a patient afflicted with a neutrophil associated inflammatory disease.
Patent AT-E208776-T1 (AT)
Inventor: SHOJI YASUO
IPC: C07D487/04
Filed: 1995-06-05
Granted: 2001-11-15
Abstract: The invention provides a pyrazoloÄ1,5-aÜpyrimidine derivative of the following formula (1): <CHEM> wherein R<1> is hydrogen, lower alkyl which may have thienyl, lower alkoxy, lower alkylthio, oxo or hydroxyl as a substituent, cycloalkyl, thienyl, furyl, lower alkenyl, or phenyl which may have 1 to 3 substituents selected from the group consisting of lower alkyl, lower alkoxy, phenylthio and halogen; R<2> is naphthyl, cycloalkyl, furyl, thienyl, optionally halogen-substituted pyridyl, optionally halogen-substituted phenoxy, or phenyl which may have 1 to 3 substituents selected from the group consisting of lower alkyl, lower alkoxy, halogen, nitro, halogen-substituted lower alkyl, halogen-substituted lower alkoxy, lower alkoxycarbonyl, hydroxyl, phenyl(lower)alkoxy, amino, cyano, lower alkanoyloxy, phenyl and di(lower)alkoxyphosphoryl(lower)alkyl; R<3> is hydrogen, phenyl or lower alkyl; R<4> is hydrogen, lower alkyl, lower alkoxycarbonyl, phenyl(lower)alkyl, optionally phenylthio-substituted phenyl, or halogen; R<5> is hydrogen or lower alkyl; R<6> is hydrogen, lower alkyl, phenyl(lower)alkyl, or benzoyl having 1 to 3 substituents selected from the group consisting of lower alkoxy, halogen-substituted lower alkyl and halogen; R<1> and R<5> may conjointly form lower alkylene; Q is carbonyl or sulfonyl; A is a single bond, lower alkylene or lower alkenylene; and n is 0 or 1. This derivative is useful as a potent analgesic.
Patent AT-E207690-T1 (AT)
Inventor: COVINO ALFRED E
IPC: H05K3/36
Filed: 1995-07-25
Granted: 2001-11-15
Abstract: Rigid flex printed circuit boards are formed with great efficiency and high yield in an assembly process wherein each circuit layer is punched in peripheral regions with alignment slots along two orthogonal radii and all layers are assembled without any acrylic bonding in a single hot press operation. A central flex layer spans a window defined in the rigid boards, and is covered with an insulating layer that overshoots the window and underlaps a rigid layer. At least the first rigid layer extends inwardly past the edge of the window, and provides a cantilevered edge support ribbon at the flex region boundary. Preferably the rigid and flex layers are all formed with a glass/epoxy material.
Patent AT-E235699-T1 (AT)
Inventor: DE DOBBELAERE PETER MARTIN CYR
IPC: G02B6/122
Filed: 1995-08-16
Granted: 2003-04-15
Abstract: The invention relates to a pigtailing method, i.e., the invention provides an optical device comprising a substrate on which are integrated a layered optical waveguide component (3) and optical fiber ends (13). The optical fiber ends are positioned in grooves (10). The method involves providing a substrate (7) comprising grooves (10), notably V-shaped grooves, with a separately made optical waveguide component (3). The component (3) is made on separate flat substrate (1), and released by virtue of a releasable layer (2) present on the flat substrate (1). An advantageous releasable layer is made of a water-soluble salt. The invention also pertains to flexible waveguide sheets such (3) as can be used in the above method or, if provided with waveguide channels (12), as a flexible waveguide component themselves.
Patent AT-E194324-T1 (AT)
Inventor: NIKANDER RISTO
IPC: C03B23/023
Filed: 1995-10-24
Granted: 2000-07-15
Abstract: PCT No. PCT/FI95/00584 Sec. 371 Date May 28, 1997 Sec. 102(e) Date May 28, 1997 PCT Filed Oct. 24, 1995 PCT Pub. No. WO96/12682 PCT Pub. Date May 2, 1996A method and an apparatus for bending and tempering of a glass sheet is disclosed. The means to be used in the method for supporting the glass sheet is a supporting device in two parts, wherein the first supporting device forms a substantially planar supporting surface for the margin of the glass sheet and the second supporting device forms, in a manner known as such, a supporting device for the margin of the glass sheet corresponding to the bending configuration. In the method, the first supporting device supports the glass sheet to maintain its planar configuration at the heating stage required for tempering, wherein the glass sheet is being heated to the tempering temperature. During heating, the glass sheet is further supported by a pressure difference imposed on the opposite surfaces of the glass sheet. After heating, the glass sheet is moved to the second supporting device to bend to the bending configuration determined by the second supporting device, followed by the tempering stage.